These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15477919)

  • 1. Rheumatologic diagnostic serology: tests which test clinicians.
    Wong ML
    N Z Med J; 2004 Oct; 117(1203):U1095. PubMed ID: 15477919
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic value of anticyclic citrullinated peptide antibody in rheumatoid arthritis.
    Jansen TL; Bruyn GA
    J Rheumatol; 2004 May; 31(5):1012-3; author reply 1013. PubMed ID: 15124273
    [No Abstract]   [Full Text] [Related]  

  • 3. Can we rely on anti-citrulline antibody determination for the diagnosis of early rheumatoid arthritis?
    Bell DA
    J Rheumatol; 2006 Dec; 33(12):2369-71. PubMed ID: 17143974
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis.
    Solanki K; Spellerberg M; Chapman P; Moller P; O'Donnell J
    N Z Med J; 2004 Oct; 117(1203):U1097. PubMed ID: 15477921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early diagnosis of rheumatoid arthritis with a test based upon a specific antigen: cyclic citrullinated peptide].
    Jansen TL
    Ned Tijdschr Geneeskd; 2003 Apr; 147(15):729-30; author reply 730-1. PubMed ID: 12722537
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis.
    Nielen MM; van der Horst AR; van Schaardenburg D; van der Horst-Bruinsma IE; van de Stadt RJ; Aarden L; Dijkmans BA; Hamann D
    Ann Rheum Dis; 2005 Aug; 64(8):1199-204. PubMed ID: 15640269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-cyclic citrullinated peptide antibody in early rheumatoid arthritis: comment on the editorial by Scott.
    van Venrooij WJ; van de Putte LB; van den Hoogen FH
    Arthritis Rheum; 2003 Mar; 48(3):857; author reply 857-8. PubMed ID: 12632446
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antibodies against citrullinated proteins--a breakthrough in rheumatologic diagnostics].
    Rönnelid J; Klareskog L; Skogh T; Svensson B
    Lakartidningen; 2004 Dec; 101(50):4092-6. PubMed ID: 15631262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of anti-cyclic citrullinated peptides antibodies in comparison with rheumatoid factor for rheumatoid arthritis diagnosis].
    Dubrous P; Gardet V; Hugard L
    Pathol Biol (Paris); 2005 Mar; 53(2):63-7. PubMed ID: 15708648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CCP antibodies as an aid to prioritization of patients referred to the rheumatology clinic.
    Madan A; Belshaw R; Grennan D
    QJM; 2007 Nov; 100(11):737-8. PubMed ID: 17951317
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical significance of anti-citrullinated peptide antibody in Japanese patients with established rheumatoid arthritis.
    Nakamura H; Kawakami A; Ida H; Origuchi T; Matsuoka N; Tsuboi M; Furuyama M; Mizokami A; Tsukada T; Nakashima M; Ejima E; Hamasaki K; Aoyagi K; Uetani M; Fukuda T; Honda S; Urayama S; Kawabe Y; Ueki Y; Mine M; Eguchi K
    Scand J Rheumatol; 2005; 34(6):489-90. PubMed ID: 16393775
    [No Abstract]   [Full Text] [Related]  

  • 12. Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review.
    Lee AN; Beck CE; Hall M
    Clin Lab Sci; 2008; 21(1):15-8. PubMed ID: 18335856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CCP antibodies: the new rheumatoid factor in the serology of rheumatoid arthritis.
    van Venrooij WJ; Vossenaar ER; Zendman AJ
    Autoimmun Rev; 2004 Jun; 3 Suppl 1():S17-9. PubMed ID: 15309772
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnostic value of anti-cyclic citrullinated peptide antibodies to detect rheumatoid arthritis in patients with Sjögren's syndrome.
    van Noord C; Hooijkaas H; Dufour-van den Goorbergh BC; van Hagen PM; van Daele PL; van de Merwe JP
    Ann Rheum Dis; 2005 Jan; 64(1):160-2. PubMed ID: 15608321
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-citrulline antibodies in psoriatic patients with and without arthritis.
    Parodi A; Drosera M; Seriolo B; Barbieri L; Rebora A
    Acta Derm Venereol; 2005; 85(3):253-4. PubMed ID: 16040413
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical value of second- and third-generation assays of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.
    Kitahara K; Takagi K; Kusunoki Y; Nishio S; Nozaki T; Inomata H; Takei M; Sawada S; Kawai S
    Ann Rheum Dis; 2008 Jul; 67(7):1059-60. PubMed ID: 18556455
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.
    Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G
    J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
    J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor.
    Bossuyt X; Coenen D; Fieuws S; Verschueren P; Westhovens R; Blanckaert N
    Ann Rheum Dis; 2009 Feb; 68(2):287-9. PubMed ID: 19139208
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-cyclic citrullinated peptide in preclinical rheumatoid arthritis. Food for thought.
    Ménard HA
    J Rheumatol; 2009 Apr; 36(4):663-4. PubMed ID: 19342718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.